Assessment of Microalbuminuria for Early Diagnosis and Risk Prediction in Dengue Infections

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Hanh Tien, Nguyen Thi ^a   Lam, Phung Khanh ^a   Duyen, Huynh Thi Le ^a   van Ngoc, Tran ^c   Ha, Phan Thi Thanh ^d   Kieu, Nguyen Tan Thanh ^a   Simmons, Cameron ^a,b   Wolbers, Marcel ^a,b   Wills, Bridget ^a,b  

^a OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^d District 8 Hospital   (Viet Nam)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ANALYTICAL PARAMETERS; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DENGUE; DESCRIPTIVE RESEARCH; DISEASE SEVERITY; EARLY DIAGNOSIS; FEMALE; FEVER; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; OUTPATIENT DEPARTMENT; POINT OF CARE TESTING; PROSPECTIVE STUDY; REFERENCE VALUE; RISK ASSESSMENT; SCHOOL CHILD; URINE ALBUMIN EXCRETION; URINE ALBUMIN TO CREATININE RATIO; VIET NAM;

EID: 84872774871     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0054538     Document Type: Article

References (35)

1. WHO (2009) Dengue guidelines for diagnosis, treatment, prevention and control.
2. Kalayanarooj S, Vaughn DW, Nimmannitya S, Green S, Suntayakorn S, et al. (1997) Early clinical and laboratory indicators of acute dengue illness. J Infect Dis 176: 313-321.
3. Cao XT, Ngo TN, Kneen R, Bethell D, Le TD, et al. (2004) Evaluation of an algorithm for integrated management of childhood illness in an area of Vietnam with dengue transmission. Trop Med Int Health 9: 573-581.
4. Gregory CJ, Lorenzi OD, Colon L, Garcia AS, Santiago LM, et al. (2011) Utility of the tourniquet test and the white blood cell count to differentiate dengue among acute febrile illnesses in the emergency room. PLoS Negl Trop Dis 5: e1400.
5. Biswas HH, Ortega O, Gordon A, Standish K, Balmaseda A, et al. (2012) Early clinical features of dengue virus infection in nicaraguan children: a longitudinal analysis. PLoS Negl Trop Dis 6: e1562.
6. Potts JA, Thomas SJ, Srikiatkhachorn A, Supradish PO, Li W, et al. (2010) Classification of dengue illness based on readily available laboratory data. Am J Trop Med Hyg 83: 781-788.
7. Klausen K, Borch-Johnsen K, Feldt-Rasmussen B, Jensen G, Clausen P, et al. (2004) Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation 110: 32-35.
8. Rein P, Vonbank A, Saely CH, Beer S, Jankovic V, et al. (2011) Relation of albuminuria to angiographically determined coronary arterial narrowing in patients with and without type 2 diabetes mellitus and stable or suspected coronary artery disease. Am J Cardiol 107: 1144-1148.
9. Smink PA, Lambers Heerspink HJ, Gansevoort RT, de Jong PE, Hillege HL, et al. (2012) Albuminuria, Estimated GFR, Traditional Risk Factors, and Incident Cardiovascular Disease: The PREVEND (Prevention of Renal and Vascular Endstage Disease) Study. Am J Kidney Dis.
10. Garcia S, Morales R, Hunter RF, (1995) Dengue fever with thrombocytopenia: studies towards defining vulnerability of bleeding. Bol Asoc Med P R 87: 2-7.
11. Vasanwala FF, Puvanendran R, Fook-Chong S, Ng JM, Suhail SM, et al. (2011) Could peak proteinuria determine whether patient with dengue fever develop dengue hemorrhagic/dengue shock syndrome?-a prospective cohort study. BMC Infect Dis 11: 212.
12. Wills BA, Oragui EE, Dung NM, Loan HT, Chau NV, et al. (2004) Size and charge characteristics of the protein leak in dengue shock syndrome. J Infect Dis 190: 810-818.
13. Bakker AJ, (1999) Detection of microalbuminuria. Receiver operating characteristic curve analysis favors albumin-to-creatinine ratio over albumin concentration. Diabetes Care 22: 307-313.
14. Duyen HT, Ngoc TV, Ha do T, Hang VT, Kieu NT, et al. (2011) Kinetics of plasma viremia and soluble nonstructural protein 1 concentrations in dengue: differential effects according to serotype and immune status. J Infect Dis 203: 1292-1300.
15. Cardosa MJ, Wang SM, Sum MS, Tio PH, (2002) Antibodies against prM protein distinguish between previous infection with dengue and Japanese encephalitis viruses. BMC Microbiol 2: 9.
16. Shu PY, Chang SF, Kuo YC, Yueh YY, Chien LJ, et al. (2003) Development of group- and serotype-specific one-step SYBR green I-based real-time reverse transcription-PCR assay for dengue virus. J Clin Microbiol 41: 2408-2416.
17. Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, et al. (2005) Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 67: 2089-2100.
18. R Core Team (2012) R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing.
19. Douglas Bates, Martin Maechler, Bolker B (2012) lme4: Linear mixed-effects models using S4 classes. R package version 0999999-0.
20. Trachtenberg F, Barregard L, (2007) The effect of age, sex, and race on urinary markers of kidney damage in children. Am J Kidney Dis 50: 938-945.
21. Rademacher ER, Sinaiko AR, (2009) Albuminuria in children. Curr Opin Nephrol Hypertens 18: 246-251.
22. Jones CA, Francis ME, Eberhardt MS, Chavers B, Coresh J, et al. (2002) Microalbuminuria in the US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis 39: 445-459.
23. Pugia MJ, Lott JA, Kajima J, Saambe T, Sasaki M, et al. (1999) Screening school children for albuminuria, proteinuria and occult blood with dipsticks. Clin Chem Lab Med 37: 149-157.
24. Thorevska N, Sabahi R, Upadya A, Manthous C, Amoateng-Adjepong Y, (2003) Microalbuminuria in critically ill medical patients: prevalence, predictors, and prognostic significance. Crit Care Med 31: 1075-1081.
25. Daoussis D, Panoulas VF, John H, Toms TE, Antonopoulos I, et al. (2011) Microalbuminuria in rheumatoid arthritis in the post penicillamine/gold era: association with hypertension, but not therapy or inflammation. Clin Rheumatol 30: 477-484.
26. Drumheller BC, McGrath M, Matsuura AC, Gaieski DF, (2012) Point-of-care urine albumin:creatinine ratio is associated with outcome in emergency department patients with sepsis: a pilot study. Acad Emerg Med 19: 259-264.
27. Carvalho JF, Blank M, Shoenfeld Y, (2007) Vascular endothelial growth factor (VEGF) in autoimmune diseases. J Clin Immunol 27: 246-256.
28. Davis JS, Yeo TW, Piera KA, Woodberry T, Celermajer DS, et al. (2010) Angiopoietin-2 is increased in sepsis and inversely associated with nitric oxide-dependent microvascular reactivity. Crit Care 14: R89.
29. Priyadarshini D, Gadia RR, Tripathy A, Gurukumar KR, Bhagat A, et al. (2010) Clinical findings and pro-inflammatory cytokines in dengue patients in Western India: a facility-based study. PLoS One 5: e8709.
30. Gregory CJ, Santiago LM, Arguello DF, Hunsperger E, Tomashek KM, (2010) Clinical and laboratory features that differentiate dengue from other febrile illnesses in an endemic area-Puerto Rico, 2007-2008. Am J Trop Med Hyg 82: 922-929.
31. Rowe DJ, Bagga H, Betts PB, (1985) Normal variations in rate of albumin excretion and albumin to creatinine ratios in overnight and daytime urine collections in non-diabetic children. Br Med J (Clin Res Ed) 291: 693-694.
32. Smulders YM, Slaats EH, Rakic M, Smulders FT, Stehouwer CD, et al. (1998) Short-term variability and sampling distribution of various parameters of urinary albumin excretion in patients with non-insulin-dependent diabetes mellitus. J Lab Clin Med 132: 39-46.
33. Incerti J, Zelmanovitz T, Camargo JL, Gross JL, de Azevedo MJ, (2005) Evaluation of tests for microalbuminuria screening in patients with diabetes. Nephrol Dial Transplant 20: 2402-2407.
34. Chau NP, Bouhanick B, Mestivier D, Taki M, Marre M, (2000) Normal and abnormal day-to-day variability of urinary albumin excretion in control and diabetic subjects. Diabetes Metab 26: 36-41.
35. Younes N, Cleary PA, Steffes MW, de Boer IH, Molitch ME, et al. (2010) Comparison of urinary albumin-creatinine ratio and albumin excretion rate in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study. Clin J Am Soc Nephrol 5: 1235-1242.